Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
|---|---|
| Enthalten in: |
Annals of hematology - 96(2016), 3 vom: 16. Nov., Seite 497-500 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Behnia, Fatemeh [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Eculizumab |
|---|
| Anmerkungen: |
© Springer-Verlag Berlin Heidelberg 2016 |
|---|
| doi: |
10.1007/s00277-016-2875-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR003942597 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR003942597 | ||
| 003 | DE-627 | ||
| 005 | 20230519235523.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201001s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00277-016-2875-8 |2 doi | |
| 035 | |a (DE-627)SPR003942597 | ||
| 035 | |a (SPR)s00277-016-2875-8-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Behnia, Fatemeh |e verfasserin |0 (orcid)0000-0002-9110-909X |4 aut | |
| 245 | 1 | 0 | |a Potential value of FDG PET-CT in diagnosis and follow-up of TAFRO syndrome |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Springer-Verlag Berlin Heidelberg 2016 | ||
| 650 | 4 | |a Pericardial Effusion |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Tocilizumab |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Hemolytic Uremic Syndrome |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Myelofibrosis |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Eculizumab |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Elojeimy, Saeed |4 aut | |
| 700 | 1 | |a Matesan, Manuela |4 aut | |
| 700 | 1 | |a Fajgenbaum, David C. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of hematology |d Berlin : Springer, 1955 |g 96(2016), 3 vom: 16. Nov., Seite 497-500 |w (DE-627)SPR003573435 |w (DE-600)1458429-3 |x 1432-0584 |7 nnns |
| 773 | 1 | 8 | |g volume:96 |g year:2016 |g number:3 |g day:16 |g month:11 |g pages:497-500 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s00277-016-2875-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 96 |j 2016 |e 3 |b 16 |c 11 |h 497-500 | ||